Last year in the UK over 60,000 cancer patients enrolled on clinical trials aimed at improving cancer treatments and making them available to all.
A trial to see if there is a link between the enzyme thymidylate synthase and how people respond to treatment for non small cell lung cancer (The TS Study)
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
More about this trial
Thymidylate synthase (TS) is a substance that the body produces naturally. Cancer cells need TS to be able to copy their DNA before they divide into 2 new cells.
Researchers think that treatment for NSCLC may work better in people who have low levels of TS in their body. But they don’t know this for sure yet. So in this trial, they measured the TS levels of everybody having treatment.
The aim of the trial was to see if there is a link between how much TS people produce and how well they respond to treatment with pemetrexed and cisplatin for non small cell lung cancer.
Summary of results
Despite attempting to contact the trial team, we have not been able to have the results for this trial checked.
How to join a clinical trial
Dr Mayukh Das
Eli Lilly and Company Limited
Experimental Cancer Medicine Centre (ECMC)